Total Intravenous Anesthesia and Recurrence Free Survival

The investigators propose to compare recurrence-free survival in patients having potentially curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.

Trial Details

NCT ID
NCT04513808
Phase
PHASE3
Sponsor
The Cleveland Clinic
Status
RECRUITING
Cancer Type
Esophageal Cancer
Interventions
  • Propofol-based total intravenous anesthesia
  • Sevoflurane intravenous anesthesia
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • Primary esophageal cancer without known extension beyond the esophagus. (i.e. believed to be Tumor Stage 1-3).
  • Scheduled for potentially curative esophageal cancer surgery.
  • Written informed consent, including willingness to be randomized to intravenous versus volatile anesthesia.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Esophageal Cancer Trials on Trialify →